Home Tools
Log in
Cart

Search Result

Search Results for " lpa1 "

20

Compounds

Cat No. Product Name Synonyms Targets
T15785 LPA1 receptor antagonist 1 LPA1 R antagonist 1 LPA Receptor
LPA1 receptor antagonist 1(LPA1 R antagonist 1) is a selective and potent lysophosphatidic acid (LPA1) receptor antagonist (IC50 : 25 nM) for the study of idiopathic pulmonary fibrosis.
T9699 TAK-615 LPA Receptor
TAK-615 is commonly used to study pulmonary fibrosis and is a negative allosteric modulator of LPA1 receptors.
T2000 AM095 LPA Receptor , LPL Receptor
AM095 is a potent LPA1 receptor antagonist with IC50 values of 0.98 and 0.73 μM for recombinant human or mouse LPA1 respectively.
T10293 AM095 free acid LPA Receptor , LPL Receptor
AM095 (free acid) is a potent LPA1 receptor antagonist (IC50s: 0.98 and 0.73 μM for recombinant human or mouse LPA1).
T4278 AM966 LPA Receptor , LPL Receptor
AM966, a excellent affinity, specific, oral LPA1(IC50=17 nM) antagonist, suppresses LPA-stimulated intracellular calcium release.
T7689 Tetradecyl Phosphonate LPA Receptor
Tetradecyl phosphonate is a pan-antagonist of lysophosphatidic acid 1 (LPA1), LPA2, and LPA3 receptors.
T7393 ONO-7300243 LPA Receptor , LPL Receptor
ONO-7300243 is an antagonist of lysophosphatidic acid receptor 1 (LPA1; IC50 : 0.16 µM).
T6347 Ki16198 LPA Receptor , LPL Receptor
Ki16198 is the methyl ester of Ki16425, which is a LPA antagonist and inhibits LPA1- and LPA3-induced inositol phosphate production with Ki of 0.34 μM and 0.93 μM, respectively, shows weaker inhibition for LPA2, no activ...
T39647 BMS-986278 LPA Receptor
BMS-986278 is an orally active and potent hemophosphatidic acid receptor 1 (LPA1) antagonist with Kb values of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively.BMS-986278 may be investigated for use in idiopathic...
T6108 Ki16425 Debio 0719 LPA Receptor , LPL Receptor
Ki16425 (Debio 0719) is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3 with Ki of 0.34 μM, 6.5 μM and 0.93 μM, respectively.
T22834 H2L 5765834 LPA Receptor , LPL Receptor
H2L 5765834 is a lysophosphatidic acid receptors antagonist
T21654 1-Oleoyl lysophosphatidic acid sodium 1-Oleoyl lysophosphatidic acid sodium salt LPA Receptor
1-Oleoyl lysophosphatidic acid sodium (1-Oleoyl lysophosphatidic acid sodium salt) salt is an Endogenous agonist of LPA1 and LPA2
T4016 BMS-986020 AM152,BMS986020 LPA Receptor , LPL Receptor
BMS-986020 (AM152) is a selective antagonist of LPA1.
T14335 ASP6432 LPA Receptor
ASP6432 is an antagonist of type 1 lysophosphatidic acid receptor (LPA1). For human LPA1 and rat LPA1, the IC50s are 11 nM and 30 nM , respectively.
T29109 VPC12249 VPC-12249,VPC 12249
VPC12249, a lysophosphatidic acid receptor type 1 (LPA1) antagonist, plays a functional role in osteoclast differentiation and bone resorption activity.
T63645 ONO-9780307
ONO-9780307 is a specific antagonist of LPA1 (lysophosphatidic acid receptor 1) (IC50: 2.7 nM).
T29113 VPC32183 VPC-32183,VPC 32183
VPC32183 is a competitive antagonist of LPA1 and LPA3 receptors.
T25847 NAEPA
NAEPA, an LPA mimetic, is a selective agonist of the lysophosphatidic acid-1 (LPA1) receptor.
T68679 VPC 32183 (S)
VPC 32183 (S) is a competitive antagonist at the LPA1 and LPA3 receptors. VPC 32183 is devoid of agonist activity at the human LPA1, LPA2 and LPA3 receptors, and, presumably, at other mammalian LPA receptors.
T28245 ONO-0300302 ONO 0300302
ONO-0300302 is a slow tight binding LPA1 antagonist (IC50: 0.16 nM) used to treat Benign Prostatic Hyperplasia. ONO-0300302 inhibits significantly an LPA-induced increase of intraurethral pressure (IUP) in rat (3 mg/kg, ...
1 2
TargetMol